enGene Therapeutics Inc. ENGN
2.41 USD +0.13 (+5.70%)
At closeNov 13, 2026, 7:58 PM EST
2.32 -0.09 -3.78%
After hours · Nov 13, 7:58 PM ET
2.17 Day range 2.50
1.44 52-week range 12.17
- YTD
- -73.31%
- 1 year
- -71.41%
ENGN revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-10-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-10-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-10-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-10-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-10-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-10-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-06-27T05:09:20.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.